Diabetes
Latest News
Tirzepatide Reduces Sleep Interruptions, Halting Almost Half of CPAP Use
Similar to other GLP-1s, tirzepatide, has been found to reduce sleep interruptions in patients with OSA and obesity.
Latest News
Intermittent Fasting Tops Calorie Restriction for Gut Health
Study finds intermittent-fasting, protein-pacing diet improved gut microbiota better than Mediterranean diet.
From the Journals
Metformin Gets a Reproductive Reprieve — For Diabetic Moms and Dads Alike
Physicians can reassure parents with diabetes about the safety of metformin use before conception and in early pregnancy.
Latest News
Metabolic Health Tied to Lower Prediabetes Risk
Compared with those in the metabolically healthy normal-weight group, the odds of prediabetes were at least two times higher in the metabolically...
Latest News
More and More Are Living With Type 1 Diabetes Into Old Age
Mortality and disability-adjusted life years (DALYs) among people with type 1 diabetes aged ≥ 65 years dropped significantly from 1990 to 2019.
Latest News
Bariatric Surgery Beats GLP-1 RAs in Reducing Mortality Risk
The reason may be greater weight loss with surgery.
Latest News
Do Artificial Sweeteners Really Help People With Diabetes?
Data suggests artificial sweeteners do not reduce disease risk, and in fact increase risk for T2D, CV disease, hypertension, and stroke.
Conference Coverage
Women with Autoimmune Liver Diseases Still Face Increased CVD Risks
Women with autoimmune hepatitis had a significantly higher cardiovascular risk compared to women without autoimmune hepatitis.
Latest News
Updated Guideline Reflects New Drugs for Type 2 Diabetes
The ACP recommends adding an SGLT-2 inhibitor or a GLP-1 agonist to metformin and lifestyle modifications in adults with inadequately controlled...
Latest News
What Toxic Stress Can Do to Health
Stress from adverse childhood experiences, which can have endocrine and other impacts, may be treated with a multidisciplinary team.
Commentary
Continuous Glucose Monitors Should Not Be Normalized
The level of proof that continuous glucose monitoring is useful in those who have type 2 diabetes or those without diabetes is low.